Journal of Pharmacy and Pharmaceutics
Formulation and Evaluation of Dexlansoprazole Delayed Release Capsules
Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS University, Mysore, India
Ganesh, G.N.K., Assistant Professor, Department of Pharmaceutics, JSS College of Pharmacy, Ooty, Nilgiris-643001, Tamil Nadu, India, E-mail: firstname.lastname@example.org
Ganesh, G.N.K., et al. Formulation and Evaluation of Dexlansoprazole Delayed Release Capsules. (2016) J Pharm Pharmaceutics 3(1): 61- 69.
© 2016 Ganesh, G.N.K. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
KeywordsDexlansoprazole; Gastro oesophageal reflux disease; Sugar spheres; Kinetic model analysis; Pelletization
Dexlansoprazole (DSP) is a proton pump inhibitor, used in the treatment of gastroesophageal reflex disease (GERD) and ulcer colitis. DSP acts by reducing the quantity of acid in the stomach. DSP is an acid liable drug which can bed egraded in acidic pH of the stomach. A coating method was employed to delay the release of drug in stomach which can prolong the pharmacological action.Sugar spheres (#25, #30) have been used as inert core material for drug coating using the technique of pelletization. Delayed coating, IR coating and ER coating of drug was done by using L-HPC-31, HPMC phthalate-55, Eudragit-RSPO and Eudragit-RLPO respectively. Among the different batches F14 formulation containing 25:75 ratio of immediate release and extended delayed release coating was selected, as retardation of the drug was observed in acidic pH of stomach.